CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash Flows from Operating Activities:
Net income (loss)	$ 8,510	$ 4,876
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Provision for credit losses on loans	0	75
Noncash contribution expense to employee stock ownership plan	373	417
Noncash director compensation expense	215	255
Stock-based compensation expense	274	168
Amortization of core deposit intangible	200	227
Amortization of investment security premiums, net of accretion of discounts	(38)	277
Accretion of discounts on acquired loans, net	5	45
Accretion of discount on subordinated notes	48	0
Net change in deferred loan origination costs/fees	77	(9)
Depreciation and amortization	263	322
Earnings on bank-owned life insurance policies	(487)	(476)
Earnings on bank-owned life insurance death benefits	(479)	(68)
Net changes in interest receivable and other assets	(5,117)	2,050
Net changes in interest payable and other liabilities	(2,759)	(3,223)
Total adjustments	(7,425)	60
Net cash provided by operating activities	1,085	4,936
Cash Flows from Investing Activities:
Purchase of available-for-sale securities	(65,196)	(33,561)
Proceeds from paydowns/maturities of held-to-maturity securities	0	44,681
Proceeds from paydowns/maturities of available-for-sale securities	59,213	18,316
Proceeds from sales of non-accrual loans	9,067	1,295
(Increase) decrease in loans receivable, net	(2,233)	8,958
Proceeds from bank-owned life insurance policies	1,177	504
Purchase of premises and equipment	(164)	(314)
Net cash provided by investing activities	1,864	39,879
Cash Flows from Financing Activities:
Net increase in deposits	12,584	81,956
Repayment of finance lease obligations	(41)	(38)
Proceeds from stock options exercised	30	0
Restricted stock surrendered for tax withholdings upon vesting	(156)	(96)
Cash dividends paid on common stock	(4,028)	(4,025)
Stock repurchased	(6)	0
Proceeds from stock issued under employee and director stock purchase plans	9	8
Net cash provided by financing activities	8,392	77,805
Net increase in cash, cash equivalents and restricted cash	11,341	122,620
Cash, cash equivalents and restricted cash at beginning of period	225,303	137,304
Cash, cash equivalents and restricted cash at end of period	236,644	259,924
Supplemental disclosure of cash flow information:
Interest paid on deposits and borrowings	12,290	10,806
Income taxes paid, net of refunds	(421)	0
Supplemental disclosure of noncash investing and financing activities:
Change in net unrealized gains or losses on available-for-sale securities	(7,642)	3,289
Amortization of net unrealized loss on available-for-sale securities transferred to held-to-maturity	$ 0	$ 340